Physicochemical and Pharmacokinetic Profiles of Gadopiclenol
Sign Up to like & getrecommendations! Published in 2019 at "Investigative Radiology"
DOI: 10.1097/rli.0000000000000563
Abstract: Abstract Objectives We aimed to evaluate gadopiclenol, a newly developed extracellular nonspecific macrocyclic gadolinium-based contrast agent (GBCA) having high relaxivity properties, which was designed to increase lesion detection and characterization by magnetic resonance imaging. Methods… read more here.
Keywords: protein binding; relaxivity; profile; gadopiclenol ... See more keywords
Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field Strength.
Sign Up to like & getrecommendations! Published in 2019 at "Investigative Radiology"
DOI: 10.1097/rli.0000000000000572
Abstract: PURPOSE The aim of this study was to evaluate in vitro and in vivo the enhancement properties of experimental gadolinium (Gd)-based contrast agents (GBCAs) with different molecular weights and hydration numbers (P846 and gadopiclenol) compared… read more here.
Keywords: p846; gadoterate; gadopiclenol; gadopentetate ... See more keywords
Efficacy and Safety of Gadopiclenol for Contrast-Enhanced MRI of the Central Nervous System
Sign Up to like & getrecommendations! Published in 2022 at "Investigative Radiology"
DOI: 10.1097/rli.0000000000000944
Abstract: Objectives Developing new high relaxivity gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI) allowing dose reduction while maintaining similar diagnostic efficacy is needed, especially in the context of gadolinium retention in tissues. This study… read more here.
Keywords: mmol; contrast; gadobutrol; gadopiclenol ... See more keywords
Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
Sign Up to like & getrecommendations! Published in 2019 at "Radiology"
DOI: 10.1148/radiol.2019182953
Abstract: Background Detection of cerebral lesions at MRI may benefit from a chemically stable and more sensitively detected gadolinium-based contrast agent (GBCA). Gadopiclenol, a macrocyclic GBCA with at least twofold higher relaxivity, is currently undergoing clinical… read more here.
Keywords: gadobenate; gadobutrol; contrast; gadopiclenol ... See more keywords